Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Southan, Mark Allen, Peter Hecht, Betsy Humphreys

Premium

Christopher Southan will join the University of Nottingham as visiting professor of proteomics in the department of biosciences. Southan is currently bioinformatics group leader in the molecular pharmacology department of AstraZeneca R&D in Möndal, Sweden, and has also held bioinformatics positions at Oxford Glycosciences (now Oxford Genome Sciences) and Gemini Genomics.


Tripos has promoted Mark Allen to senior vice president and managing director of Tripos Discovery Research, its UK-based chemistry research facility. Allen will replace Peter Hecht, who is leaving the company to become CEO of Oridis Biomed. Hecht will continue to work with Tripos as a scientific advisor, the company said. Allen joined Tripos in 1998 as director of research and analytics. Previously, Allen was head of drug discovery support for Novartis Pharma UK.


Betsy Humphreys has been appointed deputy director of the National Library of Medicine, the parent institute for the National Center for Biotechnology Information at the National Institutes of Health. Humphreys joined the NLM in 1973 and most recently served as associate director for library operations.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.